New Zealand Infectious Disease Point-of-care Testing Market (2025-2031) | Outlook, Forecast, Revenue, Trends, Analysis, Share, Size, Segmentation, Growth, Value, Companies & Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 New Zealand Country Macro Economic Indicators

3.2 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 & 2031F

3.3 New Zealand Infectious Disease Point-of-care Testing Market - Industry Life Cycle

3.4 New Zealand Infectious Disease Point-of-care Testing Market - Porter's Five Forces

3.5 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2021 & 2031F

3.6 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2021 & 2031F

3.7 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of infectious diseases in New Zealand

4.2.2 Growing focus on early diagnosis and treatment of infectious diseases

4.2.3 Technological advancements in point-of-care testing devices

4.2.4 Rising demand for rapid and accurate diagnostic solutions

4.2.5 Government initiatives to improve healthcare infrastructure

4.3 Market Restraints

4.3.1 High cost associated with point-of-care testing devices

4.3.2 Limited awareness and adoption of point-of-care testing in remote areas

4.3.3 Regulatory challenges related to approval and compliance of testing devices

4.3.4 Lack of skilled healthcare professionals for conducting point-of-care tests

4.3.5 Competition from traditional laboratory testing methods

6.1 New Zealand Infectious Disease Point-of-care Testing Market, By Applications

6.1.1 Overview and Analysis

6.1.2 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2021-2031F

6.1.3 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2021-2031F

6.1.4 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2021-2031F

6.1.5 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2021-2031F

6.1.6 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2021-2031F

6.2 New Zealand Infectious Disease Point-of-care Testing Market, By Technologies

6.2.1 Overview and Analysis

6.2.2 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2021-2031F

6.2.3 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2021-2031F

6.2.4 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2021-2031F

6.2.5 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2021-2031F

6.3 New Zealand Infectious Disease Point-of-care Testing Market, By End-users

6.3.1 Overview and Analysis

6.3.2 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021-2031F

6.3.3 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2021-2031F

6.3.4 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2021-2031F

6.3.5 New Zealand Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2021-2031F

7.1 New Zealand Infectious Disease Point-of-care Testing Market Export to Major Countries

7.2 New Zealand Infectious Disease Point-of-care Testing Market Imports from Major Countries

8.1 Adoption rate of point-of-care testing devices in healthcare facilities

8.2 Average turnaround time for test results using point-of-care devices

8.3 Number of infectious disease cases diagnosed using point-of-care testing

8.4 Rate of accuracy and reliability of point-of-care testing compared to conventional methods

8.5 Utilization rate of government-funded programs promoting point-of-care testing for infectious diseases

9.1 New Zealand Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2021 & 2031F

9.2 New Zealand Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2021 & 2031F

9.3 New Zealand Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2021 & 2031F

10.1 New Zealand Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2024

10.2 New Zealand Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters